Editor’s Take note (9/4/20): Drugmakers throughout the world are working additional time to develop vaccines for COVID-19. If delays emerge, they might require to rely on costly biotech these types of as monoclonal antibodies. In this post, Scientific American specifics yet another strategy producing progress in Costa Rica, where by […]